info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Oral Thin Film Drugs Market Research Report Information By Product (Fast Dissolving Buccal Film and Sublingual), By Disease Indication (Nausea & Vomiting, Opioid Dependence, Schizophrenia, and Migraine), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Drug Stores), And By Region (Europe, Asia-Pacific, North America, And Rest Of The World) – Market Forecast Till 2032


ID: MRFR/Pharma/5085-CR | 100 Pages | Author: Rahul Gotadki| October 2018

Oral Thin Film Drugs Market Segmentation 


Oral Thin Film Drugs Distribution Channel Outlook (USD Billion, 2018-2030)



  • Retail Pharmacies

  • Hospital Pharmacies

  • Online Drug Stores


Oral Thin Film Drugs Disease Indication Outlook (USD Billion, 2018-2030)



  • Opioid Dependence

  • Nausea & Vomiting

  • Schizophrenia

  • Migraine


Oral Thin Film Drugs Product Outlook (USD Billion, 2018-2030)



  • Fast Dissolving Buccal Film

  • Sublingual


Oral Thin Film Drugs Regional Outlook (USD Billion, 2018-2030)




  • North America Outlook (USD Billion, 2018-2030)


    • North America Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • North America Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • North America Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • US Outlook (USD Billion, 2018-2030)


    • US Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • US Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • US Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • CANADA Outlook (USD Billion, 2018-2030)


    • CANADA Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • CANADA Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • CANADA Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual





  • Europe Outlook (USD Billion, 2018-2030)






    • Europe Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Europe Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Europe Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • Germany Outlook (USD Billion, 2018-2030)


    • Germany Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Germany Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Germany Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • France Outlook (USD Billion, 2018-2030)


    • France Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • France Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • France Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • UK Outlook (USD Billion, 2018-2030)


    • UK Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • UK Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • UK Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • ITALY Outlook (USD Billion, 2018-2030)


    • ITALY Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • ITALY Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • ITALY Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • SPAIN Outlook (USD Billion, 2018-2030)


    • Spain Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Spain Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Spain Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • Rest Of Europe Outlook (USD Billion, 2018-2030)


    • Rest Of Europe Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • REST OF EUROPE Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • REST OF EUROPE Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual





  • Asia-Pacific Outlook (USD Billion, 2018-2030)






    • Asia-Pacific Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Asia-Pacific Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Asia-Pacific Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • China Outlook (USD Billion, 2018-2030)


    • China Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • China Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • China Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • Japan Outlook (USD Billion, 2018-2030)


    • Japan Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Japan Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Japan Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • India Outlook (USD Billion, 2018-2030)


    • India Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • India Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • India Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • Australia Outlook (USD Billion, 2018-2030)


    • Australia Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Australia Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Australia Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)


    • Rest of Asia-Pacific Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Rest of Asia-Pacific Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Rest of Asia-Pacific Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual





  • Rest of the World Outlook (USD Billion, 2018-2030)






    • Rest of the World Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Rest of the World Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Rest of the World Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • Middle East Outlook (USD Billion, 2018-2030)


    • Middle East Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Middle East Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Middle East Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • Africa Outlook (USD Billion, 2018-2030)


    • Africa Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Africa Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Africa Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual



    • Latin America Outlook (USD Billion, 2018-2030)


    • Latin America Oral Thin Film Drugs by Distribution Channel

      • Retail Pharmacies

      • Hospital Pharmacies

      • Online Drug Stores




    • Latin America Oral Thin Film Drugs by Disease Indication

      • Opioid Dependence

      • Nausea & Vomiting

      • Schizophrenia

      • Migraine




    • Latin America Oral Thin Film Drugs by Product

      • Fast Dissolving Buccal Film

      • Sublingual





Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Report Prologue

2 Introduction

2.1 Definition 13

2.2 Scope of the Study 13

2.3 List of Assumptions 14

2.4 Market Structure 14

3 Research Methodology

3.1 Research Process 16

3.2 Primary Research 17

3.3 Secondary Research 18

3.4 Market Size Estimation 19

3.5 Forecast Model 19

4 Market Dynamics

4.1 Overview 21

4.2 Drivers 22

4.2.1 Growing demand for oral thin film drugs 22

4.2.2 Increasing geriatric population 22

4.3 Restraints 23

4.3.1 Drugs which irritate the mucosa or causes ulcers cannot be administrated by the oral route 23

4.3.2 Drug with a small dosage form can only be administrated 23

4.3.3 Drugs which are unstable at buccal pH cannot be administered 23

4.3.4 Stringent regulations 24

4.4 Opportunities 24

4.4.1 Introduction of oral thin film drugs in developing regions 24

4.4.2 Increasing investments in research & innovations 24

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 26

5.1.1 Bargaining Power of Suppliers 26

5.1.2 Bargaining Power of Buyers 27

5.1.3 Threat of New Entrants 27

5.1.4 Threat of Substitutes 27

5.1.5 Intensity of Rivalry 27

5.2 Value Chain Analysis 28

5.2.1 Research & Development 28

5.2.2 Manufacturing 28

5.2.3 Distribution & Sales 28

5.2.4 Post-Sales Monitoring 28

5.3 Investment Opportunities 29

5.4 Macroeconomic Indicators 29

6 Global Oral Thin Film Drugs Market by Product

6.1 Overview 31

6.2 Fast Dissolving Buccal Film 32

6.3 Sublingual 32

7 Global Oral Thin Film Drugs Market by Disease Indication

7.1 Overview 34

7.2 Schizophrenia 35

7.3 Migraine 36

7.4 Opioid Dependence 36

7.5 Nausea and Vomiting 37

8 Global Oral Thin Film Drugs Market by Distribution Channel

8.1 Overview 39

8.2 Retail Pharmacies 40

8.3 Online Drug Stores 40

8.4 Hospital Pharmacies 41

9 Global Oral Thin Film Drugs Market by Region

9.1 Overview 43

9.2 Americas 44

9.2.1 North America 46

9.2.1.1 US 47

9.2.1.2 Canada 48

9.2.2 South America 49

9.3 Europe 51

9.3.1 Western Europe 53

9.3.1.1 Germany 54

9.3.1.2 France 55

9.3.1.3 UK 56

9.3.1.4 Italy 57

9.3.1.5 Spain 58

9.3.1.6 Rest of Western Europe 59

9.3.2 Eastern Europe 60

9.4 Asia-Pacific 62

9.4.1 Japan 64

9.4.2 China 65

9.4.3 India 66

9.4.4 Australia 67

9.4.5 South Korea 68

9.4.6 Rest of Asia-Pacific 69

9.5 Middle East & Africa 70

9.5.1 Middle East 72

9.5.2 Africa 73

10 Competitive Landscape

10.1 Overview 75

10.2 Company Share Analysis 75

11 Company Profiles

11.1 Johnson & Johnson Services, Inc. 77

11.1.1 Company Overview 77

11.1.2 Financial Overview 77

11.1.3 Products Offering 77

11.1.4 Key Developments 78

11.1.5 SWOT Analysis 78

11.1.6 Key Strategy 78

11.2 Pfizer Inc. 79

11.2.1 Company Overview 79

11.2.2 Financial Overview 79

11.2.3 Products/Services Offering 79

11.2.4 Key Developments 80

11.2.5 SWOT Analysis 80

11.2.6 Key Strategy 80

11.3 CURE Pharmaceutical 81

11.3.1 Financial Overview 81

11.3.2 Products/Services Offering 81

11.3.3 Key Developments 81

11.3.4 SWOT Analysis 82

11.3.5 Key Strategy 82

11.4 Novartis AG 83

11.4.1 Company Overview 83

11.4.2 Financial Overview 83

11.4.3 Products Offering 84

11.4.4 Key Developments 84

11.4.5 SWOT Analysis 84

11.4.6 Key Strategy 84

11.5 LTS Lohmann Therapie-Systeme AG 85

11.5.1 Company Overview 85

11.5.2 Financial Overview 85

11.5.3 Products Offering 85

11.5.4 Key Developments 85

11.5.5 SWOT Analysis 86

11.5.6 Key Strategy 86

11.6 GlaxoSmithKline Plc (GSK) 87

11.6.1 Company Overview 87

11.6.2 Financial Overview 87

11.6.3 Products Offering 88

11.6.4 Key Developments 88

11.6.5 SWOT Analysis 88

11.6.6 Key Strategy 88

11.7 Indivior plc 89

11.7.1 Company Overview 89

11.7.2 Financial Overview 89

11.7.3 Products Offering 90

11.7.4 Key Developments 90

11.7.5 SWOT Analysis 90

11.7.6 Key Strategy 90

12 Appendix

12.1 Discussion Blue Print 92

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.